NCT06872983

Brief Summary

The aim of the study is to evaluate the effect of cyanoacrylate adhesive in laparoscopic sacrocolpopexy, which is the gold standard treatment for apical prolapse. The procedure is predominantly performed using minimally invasive techniques, such as laparoscopic or robotic methods. However, the operative time for this procedure often exceeds 180 minutes due to its technical complexity. Although the experience level of the surgical team can lead to a decrease in operative time, there is a concerning increase in the risk of postoperative complications as the duration of surgery extends. One strategy to mitigate overall operative time is to reduce the fixation time of the implant to the vaginal wall. Standard fixation involves using several sutures, but alternative fixation methods, including barbed sutures and cyanoacrylate adhesives, may demonstrate a reduction in fixation time. While there are only a few studies available on the use of cyanoacrylate adhesives for implant fixation, they generally indicate that this method is safe and can achieve an objective success rate of over 96% in resolving apical descent. However, the reported operative time using glue varies significantly across studies, ranging from 69 to 173 minutes. The aim of the current study is to assess the impact of a synthetic cyanoacrylate-based tissue adhesive on various factors, including implant fixation time, overall length of surgery, short- and long-term postoperative complications, risk of prolapse recurrence, and the cost-effectiveness of this method in comparison to traditional laparoscopic sutures. This will be conducted as a randomized prospective monocentric study that includes patients aged 18 to 75 years diagnosed with pelvic organ descent grade 2 or higher. Notably, individuals requiring uterine preservation, having undergone previous hysterectomy, or with precancerous or malignant uterine diseases will be excluded. The surgical approach will involve fixing the implant to the vaginal wall with cyanoacrylate adhesive in the target group, along with non-absorbable sutures. In contrast, the control group will follow traditional fixation methods using absorbable sutures in addition to non-absorbable ones. The study will evaluate outcomes using various questionnaires, including the POPQ for anatomical effect and PFDI-20 for subjective discomfort, while also assessing postoperative pain through the VAS scale. Expected results include a targeted reduction in implant fixation time by at least 20 minutes and a comprehensive evaluation of the method's cost-effectiveness based on reports from Brno University Hospital. This study is significant as it represents the first prospective randomized trial to investigate the effects of cyanoacrylate adhesive on operative time and cost-effectiveness compared to conventional suturing in laparoscopic sacrocolpopexy

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Mar 2025Dec 2027

First Submitted

Initial submission to the registry

March 3, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

March 11, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

March 3, 2025

Last Update Submit

March 18, 2025

Conditions

Keywords

laparoscopic sacrocolpopexyTissue AdhesiveSurgical Gluecyanoacrylate glueimplant fixationmesh fixation

Outcome Measures

Primary Outcomes (1)

  • The duration of fixation of the implant to the walls of the vagina with the adhesive in comparison to the standard suture.

    To determine whether or not the duration of fixation of the implant to the anterior and posterior vaginal walls using adhesive is statistically significantly shorter in minutes compared to standard fixation using sutures. The statistical evaluation will be based on time measured with a stopwatch (minutes). The time is measured from the start of fixation of the implant to the vaginal walls until it is completely anchored to the vaginal walls. This objective does not evaluate the time required for complete fixation of the implant including fixation to the promotorium, but only the time required to fix the implant to the vagina.

    Enrollment to surgery: 4-8 weeks

Secondary Outcomes (13)

  • Total mesh fixation time

    Enrollment to surgery: 4-8 weeks

  • Total time of the operation

    Enrollment to surgery: 4-8 weeks

  • Peri- and post-operative complications

    From surgery to 12 months

  • Perioperative pain intensity and analgetic utilization

    intervals: 6, 24 and 48 hours after surgery

  • Recurrence rate of pelvic organ prolapse

    6 to 12 months

  • +8 more secondary outcomes

Study Arms (2)

Glue mesh fixation

EXPERIMENTAL

The mesh will be fixed to the vaginal walls using cyanoacrylate tissue adhesive.

Procedure: cyanoacrylate tissue adhesive beside sutures

Standard Care (Control):

ACTIVE COMPARATOR

The mesh will be fixed to the vaginal walls using a standard absorbable suture.

Procedure: Suture

Interventions

A supracervical hysterectomy will be performed in the standard manner. Uterine amputation above the cervix will be performed with a monopolar needle or scissors. Concomitant adnexal surgery will be performed according to the presence of adnexa and the patient's request or medical indication. In this study group, the implant is secured to the vaginal wall with cyanoacrylate tissue adhesive. Fixation of the implant to the cervix and promontory will be identical to the control group.

Glue mesh fixation
SuturePROCEDURE

A supracervical hysterectomy will be performed in the standard manner. Uterine amputation above the cervix will be performed with a monopolar needle or scissors. Concomitant adnexal surgery will be performed according to the presence of adnexa and the patient's request or medical indication. In this control group, the mesh will be fixed to the cervix with four non-absorbable sutures. In addition, the implant will be fixed to the anterior vaginal wall with four absorbable sutures and to the posterior vaginal wall with four absorbable sutures. The implant will be secured to the promontory with one non-absorbable suture.

Standard Care (Control):

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsCisgender females
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sufficient knowledge of the Czech language
  • Pelvic organs prolapse of second stage or higher according to POPQ classification (POPQ ≥ 2)
  • Patients indicated for laparoscopic sacropexy - sacrocervicopexy with concomitant supracervical hysterectomy

You may not qualify if:

  • Patients requesting uterine preservation
  • Patients with previous hysterectomy
  • Patients with premalignancy or malignancy of the female reproductive organs
  • Concomitant urethropexy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brno University Hospital

Brno, Czech Republic, 62500, Czechia

RECRUITING

MeSH Terms

Interventions

Sutures

Intervention Hierarchy (Ancestors)

Surgical Fixation DevicesSurgical EquipmentEquipment and Supplies

Study Officials

  • Samuel Tvarozek, MD

    Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Samuel Tvarozek, MD

CONTACT

Martina Szypulová, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 3, 2025

First Posted

March 12, 2025

Study Start

March 11, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

March 20, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations